How did the pandemic impact the role of women in science? And what will its legacy be? These were just some of the questions discussed at the Snapshots of Women in COG: Scientific excellence during the COVID-19 pandemic book launch event
Combining bold scientific leadership, deep operational expertise, and a knack for building community, Cristina Ariani is ready to take up her new role at the Sanger Institute and drive public health impact
The Sanger Institute’s new Respiratory Virus and Microbiome Initiative will lead the way in developing the genomic tools and methodology to study and track a range of viruses and understand how they interact with the respiratory microbiome and human hosts.
Celebrating the 2022 Queen’s Baton Relay
Meet the next generation of genomic scientists who are benefiting from our founder's generosity
Wellcome Sanger Institute Blog. Stories from the cutting edge of genomic research.
Sanger Science
Sanger Life
COVID-19
Human Cell Atlas
Tree of Life
Connect with us on Twitter
First comprehensive study of somatic mutations in normal human small intestine reveals APOBEC1 enzyme is likely responsible for two mutational signatures found in many cancers in the small intestine
Read more ⤵️
âCollateral damage‘ from normal cell function may cause mutations that play a role in cancer - Wellcome Sanger Institute
First comprehensive study of somatic mutations in normal human small intestine links APOBEC1 enzyme to two mutational signatures
www.sanger.ac.uk
Ahead of #WorldCancerDay, our Director Sir Mike Stratton unveiled a plaque celebrating those involved in the landmark discovery of the #BRCA2 #Cancer gene in 1995 🎉
Prof Stratton led the research at the @ICR_London which used @sangerinstitute sequencing 🧬
Our latest blog features Cristina Ariani @MalariaGEN, discussing #malaria surveillance.
MalariaGEN have just released 20k+ whole-genome sequences of P. falciparum, including samples taken from dried blood spots using a technique that Cristina developed.
https://sangerinstitute.blog/2023/01/20/meet-cristina-ariani-malaria-parasite-surveillance-lead/
